Metera Pharmaceuticals
Somerville, US · Founded 2016 · Delaware corporation
Founders & leadership
MC
Meredith C. Fisher, Ph.D.Named on SEC filing
ML
Marc Lenburg, Ph.D.Named on SEC filing
Reported raises · per SEC filings
Form D private placements$8.6M disclosed across 1 round · 2016
▶$8.6MraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$8.6MraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Meredith C. Fisher, Ph.D.Director
- Marc Lenburg, Ph.D.Executive Officer, Director
- Offering amount
- $8.6M
- Amount sold
- $8.6M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Metera Pharmaceuticals raised?
- Metera Pharmaceuticals has disclosed $8.6M raised across 1 round.
- Where is Metera Pharmaceuticals headquartered?
- Metera Pharmaceuticals is headquartered in Somerville, US.